Advertisement

Topics

Latest "Elliott" News Stories - Page: 3

15:15 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Elliott" found in our extensive news archives from over 250 global news sources.

More Information about Elliott on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Elliott for you to read. Along with our medical data and news we also list Elliott Clinical Trials, which are updated daily. BioPortfolio also has a large database of Elliott Companies for you to search.

Showing "Elliott" News Articles 51–69 of 69

Possibly Relevant

MJardin Group Announces Closing of GrowForce Acquisition To Create The Preeminent Global Cannabis Management Platform

MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR), a leader in cannabis management, today announced the closing of its acquisition of GrowForce Holdings Inc. (“GrowForce”), a vertically integrated international cannabis platform headquartered in Toronto and the release to the Company of the net proceeds of GrowForce’s July 2018 sub...


Monarch Medical Technologies Appoints Expert in Pediatric Diabetes, Dr. Mark Vanderwel, to Medical Advisory Board

The Leader in Electronic Systems for Inpatient Glycemic Management Adds Dr. Mark Vanderwel as an Adviser to Support Company in Advancing Diabetes Management for Pediatric Patients. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatien

Bioasis Announces Voting Results for 2018 Annual and Special Meeting

Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatment of


Children’s Hospital Los Angeles Launches Fourth Annual Make March Matter® Fundraising Campaign

More than 100 Southern California businesses will rally individuals to raise $1 million during March in support of pediatric care and research at CHLA Children’s Hospital Los Angeles (CHLA) launched its fourth annual

Smithfield Foods Donates More Than 30,000 Pounds of Protein to Gleaners Food Bank of Indiana

Kroger Joins the First Stop of Smithfield’s 2019 Helping Hungry Homes® Tour SOURCE: Smithfield Foods DESCRIPTION:INDIANAPOLIS, January 24, 2019 /3BL Media/– On January 23rd, Smithfield Foods, Inc. and Kroger joined forces to donate more than 30,000 pounds of protein to Gleaners Food Bank of Indiana. Smithfield’s contribution was part of the company’s 2019 Helping Hungry Homes® donation ...

Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV.V; OTCQX: CVALF), an advanced medical technologies company, today announces that it has entered into a definitive agreement to acquire AquaGuard, the Seattle, Washington-based division of medical technologies company Cenorin, LLC. AquaGuard’s specialized products provide patie...

St. Joseph’s Medical Center Partners with Dynafios to Launch Comprehensive Orthopedic and Spine Program

Central California Hospital Renews Dynafios Physician Alignment Program to Further Enhance the Patient Experience SEATTLE (PRWEB) September 24, 2018 Dynafios, a leading analytics and healthcare consulting company revolutionizing the business of healthcare, is pleased to announce that St. Joseph’s Medical Center successfully launched a new edge-to-edge patient focused Orthopedic and Spine Progra...

Ryan Murphy and David Miller Donate $10 Million to Children’s Hospital Los Angeles

The couple’s son received lifesaving care at CHLA, which will name a floor in his honor On behalf of the Ford Theodore Miller Murphy Family, Emmy-Award winning writer, producer and director Ryan Murphy and his husband, photographer David Miller, have made a landmark $10 million gift to Children’s Hospital Los Angeles (CHLA). In honor of this incred...

MJardin Group Announces Definitive Agreement With GrowForce To Create The Preeminent Global Cannabis Management Platform

MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR), a leader in cannabis management, today announced it has signed a definitive agreement to acquire 100% of the outstanding shares of GrowForce Holdings Inc. (“GrowForce”), a vertically integrated international cannabis platform headquartered in Toronto. The definitive agreemen...

Innate Pharma announces data presentations at upcoming scientific meetings

Innate Pharma announces data presentations at upcoming scientific meetings Updated long term follow-up data and new data from cohort expansion in the Phase I of IPH4102 in advanced CTCL at the EORTC CLTF 2018 Meeting Updated data from Phase I/II fully-enrolled study of monalizumab in combination with cetuximab in SCCHN at the ESMO 2018 congress Marseille, France, September 10...

INNATE PHARMA : first patient in the Phase I study of IPH5401 in combination with durvalumab

Innate PHARMA announces enrollment of first patient in the phase i study of IPH5401 in combination with durvalumab (IMFINZI®) in solid tumors IPH5401 is a first-in-class antibody targeting the C5a receptor expressed on subsets of myeloid-derived suppressor cells (MDSC) and neutrophils in the tumor microenvironment IPH5401 combined with PD-1/PD-L1 blocka...

Horizon Discovery and Rutgers University form exclusive partnership to develop next generation novel gene editing technology.

Horizon will work with Rutgers University to develop and commercialise base editing platform for therapeutic and research applications New gene editing technology builds on CRISPR and has the potential to assist in the development and treatment of a number of genetic diseases and cancers Cambridge, UK, 28 January 2019: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or...

Horizon Discovery Group plc enters an exclusive partnership with C4X Discovery Holdings plc to validate targets and develop next-generation oncology drugs

Cambridge, UK, 17 December 2018: Horizon Discovery Group plc (AIM: HZD), a global leader in the application of gene editing and gene modulation technologies, today announces that it has entered into an exclusive target discovery partnership with C4X Discovery Holdings plc (AIM: C4XD) ("C4XD"), a pioneering drug discovery company. The partnership aims to validate the novel synthetic ...

Innate Pharma presented translational data from the Phase II of monalizumab and cetuximab at SITC

SITC 2018: FURTHER ANALYSES OF THE PHASE II STUDY OF THE COMBINATION OF MONALIZUMAB AND CETUXIMAB IN HEAD AND NECK PATIENTS SHOW ENCOURAGING SURVIVAL DATA IN BOTH SUBGROUPS OF IO-NAÏVE AND IO-PRETREATED SCCHN PATIENTS These data support the advancement of the clinical program, starting with the enrollment of an additional cohort of patients who received both prior platinum-bas...

Tilray® Closes Transaction Acquiring Manitoba Harvest, the World’s Largest Hemp Foods Company

Closing of acquisition officially unites cannabis pioneer with leading natural food CPG company with vision to create hemp and CBD-infused food and wellness products for North America Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, is pleased to announce the...

INNATE PHARMA : Third quarter 2018 report

Innate Pharma Third quarter 2018 Report Acceleration of becoming a fully integrated oncology-focused biotech company through a recent landmark deal with AstraZeneca Expansion of oncology development collaboration with AstraZeneca validates Innate's leadership in immuno-oncology discovery Strengthens financial runway by $242 million in total near-term cash proceeds

Tilray® to Acquire Manitoba Harvest, the World’s Largest Hemp Food Company

Acquisition unites cannabis pioneer with leading natural food CPG company to create hemp and CBD-infused food and wellness products for North America Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced it has entered into a definitive agreement (...

Innate Pharma appoints experts to new Strategic Advisory Board

Innate PHARMA APPOINTS EXPERTS TO NEW strategic advisory board Marseille, France, November 20, 2018, 07:00 AM CEST Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announced the appointment of six leading experts to its newly formed Strategic Advisory Board (SAB). The SAB will work with the leadership team and will advise the Company ...

MJardin Group Announces Merger With GrowForce To Create The Preeminent Global Cannabis Management Platform

Merger Positions MJardin for Global Growth as Company Begins Trading on the Canadian Securities Exchange MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR), a leader in cannabis management, today announced a binding letter of intent (the “LOI”) to acquire GrowForce Holdings Inc. (“GrowForce”), a vertically integrated internati...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks